AT352272B - Verfahren zur herstellung von neuen 2-nied. alkyl-7-substituierten 3-cephem-4-carbonsaeure- verbindungen - Google Patents

Verfahren zur herstellung von neuen 2-nied. alkyl-7-substituierten 3-cephem-4-carbonsaeure- verbindungen

Info

Publication number
AT352272B
AT352272B AT727576A AT727576A AT352272B AT 352272 B AT352272 B AT 352272B AT 727576 A AT727576 A AT 727576A AT 727576 A AT727576 A AT 727576A AT 352272 B AT352272 B AT 352272B
Authority
AT
Austria
Prior art keywords
cephem
substituted
alkyl
low
carbonic acid
Prior art date
Application number
AT727576A
Other languages
English (en)
Other versions
ATA727576A (de
Inventor
Takashi Kamiya
Tsutomu Teraji
Masashi Hashimoto
Osamu Nakaguti
Teruo Oku
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4067775A external-priority patent/GB1554723A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ATA727576A publication Critical patent/ATA727576A/de
Application granted granted Critical
Publication of AT352272B publication Critical patent/AT352272B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT727576A 1975-10-03 1976-09-30 Verfahren zur herstellung von neuen 2-nied. alkyl-7-substituierten 3-cephem-4-carbonsaeure- verbindungen AT352272B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4067775A GB1554723A (en) 1975-10-03 1975-10-03 Cephalosporin derivatives and the preparation thereof
GB5049875 1975-12-09

Publications (2)

Publication Number Publication Date
ATA727576A ATA727576A (de) 1979-02-15
AT352272B true AT352272B (de) 1979-09-10

Family

ID=26264472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT727576A AT352272B (de) 1975-10-03 1976-09-30 Verfahren zur herstellung von neuen 2-nied. alkyl-7-substituierten 3-cephem-4-carbonsaeure- verbindungen

Country Status (5)

Country Link
JP (1) JPS5246093A (de)
AT (1) AT352272B (de)
DE (1) DE2644335A1 (de)
FR (1) FR2326196A1 (de)
NL (1) NL7610898A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI771866A (de) * 1976-06-28 1977-12-29 Fujisawa Pharmaceutical Co
JPS55166637A (en) * 1979-06-12 1980-12-25 Konishiroku Photo Ind Co Ltd Manufacture of silver halide photographic emulsion
JPS561041A (en) * 1979-06-16 1981-01-08 Konishiroku Photo Ind Co Ltd Manufacture of silver halide photographic emulsion
JPS56109335A (en) * 1980-02-05 1981-08-29 Konishiroku Photo Ind Co Ltd Manufacture of silver halide photographic emulsion
KR20200145870A (ko) 2019-06-10 2020-12-31 삼성전자주식회사 반도체 장치

Also Published As

Publication number Publication date
NL7610898A (nl) 1977-04-05
ATA727576A (de) 1979-02-15
FR2326196B1 (de) 1980-04-18
JPS6139952B2 (de) 1986-09-06
JPS5246093A (en) 1977-04-12
FR2326196A1 (fr) 1977-04-29
DE2644335A1 (de) 1977-04-14

Similar Documents

Publication Publication Date Title
ATA283676A (de) Verfahren zur herstellung von neuen phenylalkancarbonsaure-derivaten
AT341512B (de) Verfahren zur herstellung von neuen biphenylathern
ATA440876A (de) Verfahren zur herstellung von neuen adriamycinestern
AT353963B (de) Verfahren zur herstellung von neuen 2-nied. alkyl-7-subst.-2- oder -3-cephem-4-carbon- saeureverbindungen
AT351675B (de) Verfahren zur herstellung von neuen clavulan- saeurethioaethern
AT350736B (de) Verfahren zur herstellung von neuen apovin- caminolestern
AT352272B (de) Verfahren zur herstellung von neuen 2-nied. alkyl-7-substituierten 3-cephem-4-carbonsaeure- verbindungen
AT342078B (de) Verfahren zur herstellung von neuen vinylthionophosphorsaureestern
AT347963B (de) Verfahren zur herstellung von neuen 4- halogenazetidinon-1-essigsaeurederivaten
AT344901B (de) Verfahren zur herstellung von neuen penicillinen
AT343682B (de) Verfahren zur herstellung von neuen o-pyrazolopyrimidinthionothiolphosphorsaureestern
AT348118B (de) Verfahren zur herstellung von neuen beta- lactamantibiotika
AT354653B (de) Verfahren zur herstellung von neuen d-homosteroiden
AT352714B (de) Verfahren zur herstellung von neuen nitroimi- dazolylvinylthiadiazolen
AT341541B (de) Verfahren zur herstellung von neuen zinnhaltigen triazino-benzimidazolen
AT351188B (de) Verfahren zur herstellung von neuen 1,3- benzodioxan-prostansaeurederivaten
AT358598B (de) Verfahren zur herstellung von neuen barbitur- saeurekomplexen
AT352919B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT342555B (de) Verfahren zur herstellung von neuen 2-methyl-3-buten-3-halogen-2-olen
AT329750B (de) Verfahren zur herstellung von neuen 2-nied. alkyl-2- oder -3-cephem-4-carbonsaurederivaten
AT332548B (de) Verfahren zur herstellung von neuen 2-nied. alkyl-3-cephem -4- carbonsaurederivaten
AT334526B (de) Verfahren zur herstellung von neuen 2-nied. alkyl-2- oder -3-cephem-4-carbonsaurederivaten
AT357701B (de) Verfahren zur herstellung von neuen d-homo- steroiden
ATA10079A (de) Verfahren zur herstellung von neuen 2-nied. alkyl-7-subst.-2- oder -3-cephem-4-carbon- saeureverbindungen
AT352124B (de) Verfahren zur herstellung von neuen benzo- pyranderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee